PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data
Abstract
Authors
L. Jönsson R. Sandin P. Lindgren J. Kowalski T. Wahlgren U. Harmenberg P. Sandström B. Ljungberg M. Jakobsson